The treatment of Mtb-infected rabbits with bevacizumab, a monoclonal VEGF neutralizing antibody, resulted in normalization of granuloma-associated blood vessels, which promoted increased oxygenation of granulomas and more effective delivery of a molecular tracer into the granuloma necrotic core (Datta et al., 2015). This evidence concerns the gene VEGFA and Granuloma.